All products

The Inspirer DX Analyzer is a groundbreaking diagnostic platform that redefines precision in biomarker detection. Surpassing the limitations of traditional methods, the Inspirer DX Analyzer utilizes revolutionary single-molecule immunoassay technology, allowing for the quantification of trace proteins at the femtogram level. It serves as the optimal solution for the early diagnosis of neurological diseases (such as Alzheimer's), cardiovascular conditions, and pharmaceutical research with absolute accuracy.

Harnessing cutting-edge Digital Immunochip technology, these kits enable the precise quantification of Beta-Amyloid (1-40 and 1-42) at the femtogram level. A non-invasive solution designed to assess cortical amyloid burden and cognitive decline risk through the Aβ42/40 ratio—a key metric highly correlated with amyloid PET positivity.

Harnessing revolutionary Digital Immunochip technology, this kit delivers 1,000x greater sensitivity than traditional assays for quantifying Neurofilament Light chain (NfL) in human plasma. A non-invasive diagnostic tool essential for monitoring neurodegeneration, brain atrophy, and clinical progression in Alzheimer's (AD), Multiple Sclerosis (MS), and Traumatic Brain Injury (TBI).

Delivering 1,000x greater sensitivity than conventional assays, the iomics GFAP Detection Kit (Digital Immunochip Method) enables precise quantification of astrocyte activation directly from blood samples. It provides a superior, non-invasive diagnostic solution for differentiating Alzheimer’s Disease (AD) from other cognitive disorders and monitoring pathological progression through amyloid burden and neuronal loss.

Optimized for the Inspirer DX platform, the Human p-Tau231 Detection Kit (Digital Immunochip Method) provides a reliable, objective quantitative measure of p-Tau231 levels in human plasma. Classified as a core Alzheimer’s Disease (AD) fluid biomarker, it empowers clinicians to identify and manage disease progression with unprecedented precision at the femtogram level.

Powered by proprietary Digital Immunochip technology, the iomics p-Tau217 kit delivers diagnostic accuracy comparable to Cerebrospinal Fluid (CSF) biomarkers through a non-invasive blood test. With femtogram-level sensitivity, it enables precise Alzheimer’s Disease (AD) pathology identification in the pre-dementia stage, empowering clinicians and researchers with absolute data confidence.

The Human p-Tau181 Protein Detection Kit (Digital Immunochip Method) by iomics Biosciences is a cutting-edge auxiliary diagnostic tool for Alzheimer’s disease. Delivering 1,000x higher sensitivity than traditional ELISA, it enables precise quantification of p-Tau181 in human plasma at femtogram levels, identifying pathological biomarkers 10-20 years before clinical symptoms manifest.

Step into the future of digital pathology with the IBL300 – an automated slide scanning solution that converts physical glass slides into high-resolution digital data. Featuring advanced Z-stack scanning technology and ultra-fast processing, the IBL300 replaces traditional optical microscopes and enables real-time remote consultation and global online collaboration, ensuring standardized and highly accurate clinical diagnosis.

Empower your diagnostic workflow with the IBL500 – a high-throughput digital slide scanner designed for high-volume pathology departments. Featuring continuous loading capabilities and advanced Z-stack imaging, the IBL500 transforms physical slides into crystal-clear digital data, enabling seamless storage, remote consultation, and AI-driven diagnostic support.

In the fast-paced environment of modern pathology, precision and speed are non-negotiable. The LBP-2024 Automatic Sample Transfer Machine is engineered to transform your pre-analytical workflow by automating the entire sample handling process. Featuring a unique double-module design, it delivers "Double Flux, Double Efficiency," ensuring that your laboratory meets the highest standards of throughput and accuracy with minimal manual intervention.

Elevate your laboratory's productivity with the LBP-4032 – a semi-automatic sedimentation-type liquid-based cytology (LBC) system. Designed with intelligent dual-module technology, this device not only optimizes workflow but also ensures superior slide quality, providing essential support for early cancer detection and cytopathological diagnosis.

Enhance diagnostic accuracy in cytopathology with the specialized LBC Reagent kit from Guangzhou LBP. This comprehensive solution is engineered to optimize sample preservation, transportation, and processing, ensuring cell structures remain intact for critical cancer screening and pathological analysis.